Search

Your search keyword '"Lumiracoxib"' showing total 10 results
Start Over Descriptor "Lumiracoxib" Publication Type News
10 results on '"Lumiracoxib"'

1. Patent Application Titled 'Treatment Of Peanut Allergy With Tolerizing Nanoparticles' Published Online (USPTO 20240197866)

Subjects
Nonsteroidal anti-inflammatory drugs, Lumiracoxib, Olopatadine hydrochloride -- Intellectual property, Immunotherapy, Doxylamine -- Intellectual property, Antihistamines -- Intellectual property, Antiasthmatic agents -- Intellectual property, Etoricoxib, Peanut allergy, Health
Abstract

2024 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2024

5. Patent Issued for Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients (USPTO 11278618)

Subjects
Novartis AG -- Intellectual property, Psoriasis -- Development and progression, Nonsteroidal anti-inflammatory drugs, Lumiracoxib, Amino acids -- Intellectual property, Auranofin -- Intellectual property, Arthritis -- Development and progression, Etoricoxib, Pharmaceutical industry -- Intellectual property, Health
Abstract

2022 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent by the inventors Ligozio, Gregory (Basking Ridge, NJ, US), Mpofu, Shephard (Oberwil, CH), [...]

Published
2022

7. Researchers Submit Patent Application, 'Compositions For Treating And/Or Preventing Cancer', for Approval (USPTO 20200237711)

Subjects
Cancer treatment, Etoricoxib, Cancer -- Prevention, Cancer prevention, Cancer research, Lumiracoxib, Clobetasone -- Intellectual property, Nonsteroidal anti-inflammatory agents, Business, Health, Health care industry
Abstract

2020 AUG 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Li, Chiang [...]

Published
2020

8. 'Immunomodulatory Oligosaccharides' in Patent Application Approval Process (USPTO 20200237793)

Subjects
Etoricoxib, Sarilumab -- Intellectual property, Antirheumatic agents -- Intellectual property, Certolizumab pegol, Rheumatoid factor, Carprofen, Lumiracoxib, Type 2 diabetes, Nonsteroidal anti-inflammatory agents, Sulfinpyrazone -- Intellectual property, Arthritis, Antiarthritic agents -- Intellectual property, Health
Abstract

2020 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A patent application by the inventors Bode, Lars (San Diego, CA); Gordts, Philip [...]

Published
2020

9. Researchers Submit Patent Application, 'Immunomodulatory Oligosaccharides', for Approval (USPTO 20200230161)

Subjects
Etoricoxib, Sarilumab -- Intellectual property, Antirheumatic agents -- Intellectual property, Certolizumab pegol, Rheumatoid factor, Carprofen, Lumiracoxib, Type 2 diabetes, Nonsteroidal anti-inflammatory agents, Sulfinpyrazone -- Intellectual property, Arthritis, Antiarthritic agents -- Intellectual property, Health
Abstract

2020 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2020

10. Patent Issued for Compounds For Use In Treating Or Preventing Cancerous Diseases (USPTO 10,287,294)

Subjects
Cabazitaxel, Pamidronate -- Intellectual property, Trifluoperazine -- Intellectual property, Monoclonal antibodies, Lumiracoxib, Nonsteroidal anti-inflammatory agents, Medical research, Amino acids -- Intellectual property, Zoledronic acid, Etoricoxib, Vaccines -- Intellectual property, Bevacizumab -- Intellectual property, Carboplatin -- Intellectual property, Nilotinib, Plerixafor, Antineoplastic agents -- Intellectual property, Lanreotide, Temsirolimus, Fulvestrant, Clofarabine, Pertuzumab, Dasatinib, Meclofenamate, Nelarabine, Ixabepilone, Diflunisal, Axitinib, Vincristine, Editors, Abiraterone, Pemetrexed, Cetuximab, Pomalidomide, Carfilzomib, Oxaprozin, Ipilimumab, Fenoprofen, Enzalutamide, Sunitinib, Carcinogenesis, Regorafenib, Crizotinib, Lapatinib, Everolimus, Tolmetin, Ponatinib, Bosutinib, Panitumumab, Ofatumumab, Sorafenib, Bendamustine, Denosumab, Vemurafenib, Pazopanib, Aflibercept, Sulindac, Health
Abstract

2019 MAY 29 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results